Redmile Group, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Neurogene Inc. Common Stock, $0.000001 par value (NGNE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Neurogene Inc. Common Stock, $0.000001 par value
Symbol
NGNE
Shares outstanding
15,729,081 shares
Disclosed Ownership
1,557,179 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:16:08 UTC
Date of event
31 Dec 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 1,557,179 0 1,557,179 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 1,557,179 0 1,557,179 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments I, L.P. 4.8% 749,610 0 749,610 /s/ Jeremy C. Green Managing Member of Redmile Group, LLC, Managing Member of Redmile Biopharma Investments I (GP), LLC, General Partner of Redmile Biopharma Investments